A woman is born with her lifetime supply of eggs. This set reserve is not replenished by new egg growth during a woman’s prime reproductive years. Only cutting-edge testing methods determine a woman’s remaining egg reserve – her supply and quantity of eggs in the ovaries.
Ovarian Reserve Tests
A woman’s ovarian reserve determines her ability to achieve a healthy and successful pregnancy. As a woman ages, her ovaries are unable to produce key fertility hormones.
These cutting-edge ovarian reserve tests are used to determine a woman’s present egg supply.
- Antral Follicle Count Test
- Day 3 FSH and E2 Test
- Clomiphene Challenge Test
- AMH Test
Antral Follicle Count Test
Counting the number of 2-9mm diameter antral follicles that can be seen with transvaginal ultrasound can estimate a woman’s ovarian reserve.
Day 3 FSH and E2 Test
Follicle Stimulating Hormone (FSH) and Estradiol Test (E2) measures the baseline of a woman’s FSH on day 3 of her menstrual cycle.
This test can indicate that a woman is close to menopause and has a low ovarian reserve. If a woman’s Day 3 FSH is elevated, her ovarian reserve is low to the point of being infertile.
Clomiphene Challenge Test
A clomiphene challenge test is a test that can discover cases of poor ovarian reserve that are still showing a normal day 3 FSH.
The Anti-Mullerian Hormone test checks the blood levels of the hormone AMH to evaluate a woman’s ovarian reserve.
A woman’s egg quality declines with her natural aging. Even with a high egg reserve, some women are unable to conceive. Growth factors may revitalize existing eggs and improve their quality – permitting conception to occur. A woman’s supply of eggs will be used up somewhere between 25 and 55 years of age. Poor genetic quality of eggs results in infertility, even when there are many eggs remaining in a woman’s ovarian reserve.
Even though a woman in her 40s may still be able to ovulate, her healthy eggs may have been depleted. The eggs are usually poor quality. Low quality eggs can lead to an increased chance of an abnormal pregnancy.
Ovarian Rejuvenation Therapy
Ovarian Rejuvenation Therapy is an innovative Assisted Reproductive Technology (ART) procedure used to wake up and coax a woman’s nonfunctioning ovaries into producing viable eggs. Dr. Hugh Melnick is one of a handful of fertility doctors offering ovarian rejuvenation therapy.
Ovarian Rejuvenation Therapy involves the injection of a woman’s Platelet Rich Plasma (PRP) directly into her ovaries. The expected clinical result from this procedure is to induce Growth Factors to help the ovaries produce good quality eggs again – even post-menopause.
Ovarian Rejuvenation Therapy Expertise
It is important to work with a fertility specialist who has the clinical experience to design an infertility treatment plan meeting your personal needs.
Your initial consultation to find out if you are a candidate for Ovarian Rejuvenation Therapy can be conducted with the Doctor via telephone, Skype or FaceTime.
- Print your intake form by clicking here
- Print your information and consent form by clicking here
- Complete, scan and email these forms to email@example.com.
To read more about Ovarian Rejuvenation Therapy, check out the Doctor’s Blog here.
Schedule your initial consultation with Dr. Hugh Melnick at Advanced Fertility Services by calling 212.369.8700 – or – clicking the icon below.